Use of intrauterine devices in nulliparous women.

[1]  Ashley L. Hodges,et al.  Highlights From the U.S. Selected Practice Recommendations for Contraceptive Use. , 2018, Nursing for women's health.

[2]  T. Faustmann,et al.  Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use. , 2017, European journal of obstetrics, gynecology, and reproductive biology.

[3]  K. Curtis,et al.  The safety of intrauterine contraception initiation among women with current asymptomatic cervical infections or at increased risk of sexually transmitted infections. , 2016, Contraception.

[4]  M. Creinin,et al.  A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement. , 2016, American journal of obstetrics and gynecology.

[5]  S. Kochhar.  UK medical eligibility criteria for contraceptive use , 2016 .

[6]  Madison,et al.  U.S. Selected Practice Recommendations for Contraceptive Use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition. , 2013, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[7]  K. Curtis,et al.  U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. , 2016, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[8]  L. Finer,et al.  Declines in Unintended Pregnancy in the United States, 2008–2011 , 2016 .

[9]  S. Achilles,et al.  Self-Administered Lidocaine Gel for Intrauterine Device Insertion in Nulliparous Women: A Randomized Controlled Trial , 2014, Obstetrics and gynecology.

[10]  J. Daugherty,et al.  Current Contraceptive Use and Variation by Selected Characteristics Among Women Aged 15-44: United States, 2011-2013. , 2015, National health statistics reports.

[11]  L. Finer,et al.  Changes in Use of Long-Acting Reversible Contraceptive Methods Among U.S. Women, 2009–2012 , 2015, Obstetrics and gynecology.

[12]  D. Apter,et al.  The Effect of Age, Parity and Body Mass Index on the Efficacy, Safety, Placement and User Satisfaction Associated With Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: Subgroup Analyses of Data From a Phase III Trial , 2015, PloS one.

[13]  L. Lopez,et al.  Interventions for pain with intrauterine device insertion. , 2015, The Cochrane database of systematic reviews.

[14]  K. Ward,et al.  Ketorolac for Pain Control With Intrauterine Device Placement: A Randomized Controlled Trial , 2015, Obstetrics and gynecology.

[15]  C. Westhoff,et al.  Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system. , 2015, Contraception.

[16]  A. Hall,et al.  Intrauterine contraception in nulliparous women: a prospective survey , 2015, Journal of Family Planning and Reproductive Health Care.

[17]  S. Reed,et al.  Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices. , 2015, Contraception.

[18]  E. Espey,et al.  Prophylactic ibuprofen does not improve pain with IUD insertion: a randomized trial. , 2015, Contraception.

[19]  G. Ekman‐Ordeberg,et al.  Novel topical formulation of lidocaine provides significant pain relief for intrauterine device insertion: pharmacokinetic evaluation and randomized placebo-controlled trial. , 2015, Fertility and sterility.

[20]  M. Ott,et al.  Contraception for Adolescents , 2014, Pediatrics.

[21]  J. Peipert,et al.  Association of Age and Parity With Intrauterine Device Expulsion , 2014, Obstetrics and gynecology.

[22]  J. Jensen,et al.  The effect of nitroglycerin on the IUD insertion experience in nulliparous women: a pilot study. , 2014, Contraception.

[23]  M. Power,et al.  Obstetrician-gynecologists and contraception: practice and opinions about the use of IUDs in nulliparous women, adolescents and other patient populations. , 2014, Contraception.

[24]  C. Raker,et al.  A prospective cohort study of pain with intrauterine device insertion among women with and without vaginal deliveries , 2014, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[25]  M. Mete,et al.  Effects of Age, Parity, and Device Type on Complications and Discontinuation of Intrauterine Devices , 2014, Obstetrics and gynecology.

[26]  L. Leeman,et al.  Misoprostol for intrauterine device insertion in nulliparous women: a randomized controlled trial. , 2014, American journal of obstetrics and gynecology.

[27]  L. Haddad,et al.  Self-administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. , 2013, Contraception.

[28]  C. Raker,et al.  Higher dose cervical 2% lidocaine gel for IUD insertion: a randomized controlled trial. , 2013, Contraception.

[29]  D. Apter,et al.  Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: A Randomized Controlled Trial , 2013, Obstetrics and gynecology.

[30]  A. Whitaker,et al.  Use of the intrauterine device among adolescent and young adult women in the United States from 2002 to 2010. , 2013, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[31]  W. M. Brown,et al.  Intrauterine device insertions: which variables matter? , 2013, Journal of Family Planning and Reproductive Health Care.

[32]  Hong Li,et al.  The effect of nitroprusside on IUD insertion experience in nulliparous women: a pilot study. , 2013, Contraception.

[33]  M. McFadden,et al.  Failed IUD insertions in community practice: an under-recognized problem? , 2013, Contraception.

[34]  K. Black,et al.  Ease of intrauterine contraceptive device insertion in family planning settings , 2012, The Australian & New Zealand journal of obstetrics & gynaecology.

[35]  Hong Li,et al.  Adolescent experience with intrauterine device insertion and use: a retrospective cohort study. , 2012, Contraception.

[36]  J. Kohn,et al.  Knowledge and likelihood to recommend intrauterine devices for adolescents among school-based health center providers. , 2012, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[37]  Gynecologists.  Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices. , 2012, Obstetrics and gynecology.

[38]  C. Swenson,et al.  Self-Administered Misoprostol or Placebo Before Intrauterine Device Insertion in Nulliparous Women: A Randomized Controlled Trial , 2012, Obstetrics and gynecology.

[39]  K. Curtis,et al.  Health Care Provider Attitudes and Practices Related to Intrauterine Devices for Nulliparous Women , 2012, Obstetrics and gynecology.

[40]  D. Apter,et al.  A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena. , 2012, Fertility and sterility.

[41]  I. Sinai,et al.  Contraceptive failure in the United States. , 2012, Contraception.

[42]  G. Brock,et al.  Retrospective review of intrauterine device in adolescent and young women. , 2011, Journal of pediatric and adolescent gynecology.

[43]  P. Murphy,et al.  A survey of provider experience with misoprostol to facilitate intrauterine device insertion in nulliparous women. , 2011, Contraception.

[44]  S. Rose,et al.  Attitudes toward long-acting reversible contraception among young women seeking abortion. , 2011, Journal of women's health.

[45]  J. Jensen,et al.  Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. , 2011, Contraception.

[46]  J. Peipert,et al.  Continuation and Satisfaction of Reversible Contraception , 2011, Obstetrics and gynecology.

[47]  M. Losch,et al.  Young women's knowledge, attitudes, and behaviors related to long-acting reversible contraceptives. , 2010, Women's health issues : official publication of the Jacobs Institute of Women's Health.

[48]  T. Raine,et al.  Attitudes and beliefs about the intrauterine device among teenagers and young women. , 2010, Contraception.

[49]  E. Wiebe,et al.  Motivation and experience of nulliparous women using intrauterine contraceptive devices. , 2010, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[50]  J. Peipert,et al.  Intrauterine contraception in Saint Louis: a survey of obstetrician and gynecologists' knowledge and attitudes. , 2010, Contraception.

[51]  T. Römer,et al.  User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): Data from an international survey , 2009, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[52]  M. Harrison‐Woolrych,et al.  A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents. , 2009, Contraception.

[53]  Lisa M. Johnson,et al.  Adolescent and young adult women's knowledge of and attitudes toward the intrauterine device. , 2008, Contraception.

[54]  C. Harper,et al.  Challenges in Translating Evidence to Practice: The Provision of Intrauterine Contraception , 2008, Obstetrics and gynecology.

[55]  J. Jensen,et al.  Subject and clinician experience with the levonorgestrel-releasing intrauterine system. , 2008, Contraception.

[56]  R. Kulier,et al.  Copper-containing, framed intrauterine devices for contraception: a systematic review of randomized controlled trials. , 2008, Contraception.

[57]  M. Kishen,et al.  Experience of IUD/IUS insertions and clinical performance in nulliparous women–a pilot study , 2008, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[58]  D. Hubacher.  Copper intrauterine device use by nulliparous women: review of side effects. , 2007, Contraception.

[59]  N. Stanwood,et al.  Young Pregnant Women’s Knowledge of Modern Intrauterine Devices , 2006, Obstetrics and gynecology.

[60]  Pai-Lien Chen,et al.  Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. , 2006, American journal of obstetrics and gynecology.

[61]  S. Weyers,et al.  Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems. , 2005, Contraception.

[62]  I. Rauramo,et al.  Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study. , 2004, Contraception.

[63]  I. Sivin.  Problems in the conduct and analysis of "A comparative randomized study of three different IUDs in nulliparous Mexican women". , 2004, Contraception.

[64]  A. Lagro-Janssen,et al.  Complications of the intrauterine device in nulliparous and parous women , 2004, The European journal of general practice.

[65]  J. Otero-Flores,et al.  A comparative randomized study of three different IUDs in nulliparous Mexican women. , 2003, Contraception.

[66]  B. Dilbaz,et al.  Analysis of risk factors associated with uterine perforation by intrauterine devices , 2003, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[67]  J. Garrett,et al.  Obstetrician‐Gynecologists and the Intrauterine Device: A Survey of Attitudes and Practice , 2002, Obstetrics and gynecology.

[68]  M. Degueldre,et al.  Return to fertility in nulliparous and parous women after removal of the GyneFix® intrauterine contraceptive system , 2002, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[69]  D. Taylor,et al.  Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. , 2001, The New England journal of medicine.

[70]  M. Vessey,et al.  Return of fertility in nulliparous women after discontinuation of the intrauterine device: comparison with women discontinuing other methods of contraception , 2001, BJOG : an international journal of obstetrics and gynaecology.

[71]  G. Rybo,et al.  Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T. , 1992, Contraception.

[72]  T. Farley,et al.  Intrauterine devices and pelvic inflammatory disease: an international perspective , 1992, The Lancet.

[73]  I. Sivin,et al.  Long-acting, more effective copper T IUDs: a summary of U.S. experience, 1970-75. , 1979, Studies in family planning.